Characteristic | n |
---|---|
No. of patients | 17 |
Age (y), median (IQR) | 69 (64.5–72) |
PSA (ng/mL), median (IQR) | 12.9 (7.23–28.37) |
Injected activity 99mTc-PSMA I&S, median (IQR) | 678 (531–740) |
ISUP grade*, no. (%) | |
2 | 1 (5.9%) |
3 | 6 (35.3%) |
4 | 2 (11.8%) |
5 | 7 (41.2%) |
Pathological stage*, no. (%) | |
pT status | |
2c | 4 (23.5%) |
3a | 2 (11.8%) |
3b | 9 (52.9%) |
4 | 1 (5.9%) |
pN status | |
0 | 2 (11.8%) |
1 | 14 (82.4%) |